表紙
市場調查報告書
商品編碼
987856

多重測定的全球市場(2020-2027)

Global Multiplex Assays Market - 2020-2027

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球多重測定市場的主要推動力是廣泛使用伴隨診斷以提高臨床試驗的安全性和有效性,優於常規單一多重測定的優勢以及製藥行業的研發。加強活動。此外,加強對新冠狀病毒感染(COVID-19)傳播的響應也有助於市場增長。

在最終用戶中,製藥和生物技術公司所佔份額最大,而按產品劃分,消耗品和試劑則是最大的領域。按地區劃分,預計北美國家將繼續控制市場。

本報告分析了全球多重分析市場,包括市場規模趨勢以及按產品,類型,技術,應用,最終用戶和地區劃分的詳細趨勢,我們正在調查主要市場的推廣/制約因素以及主要公司的概況。

目錄

第1章全球多重分析市場:分析方法/範圍

第2章全球多重檢測市場:市場定義和概述

第3章全球多重分析市場:執行摘要

第4章全球多重分析市場:市場動態

  • 影響市場的因素
    • 促進因素
    • 抑製器
    • 市場機會
    • 影響分析

第5章全球多重分析市場:工業分析

  • 波特的五種力量分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST分析
  • 價格分析
  • 監管分析
  • 贖回分析
  • 未滿足的需求
  • 專利趨勢

第6章全球多重檢測市場:冠狀病毒疾病(COVID-19)分析

  • 分析COVID-19對市場的影響
    • "電暈之前" /過去的市場情景
    • "有電暈" /當前市場情景
    • "電暈之後" /未來市場情景
  • COVID-19時尚期間的價格趨勢
  • 供需波動區域
  • 傳染病傳播期間政府對市場的態度
  • 每個製造商的戰略發展狀況
  • 結論

第7章全球多重檢測市場:按產品

  • 簡介
  • 市場規模分析和同比增長率(YoY):按產品
  • 市場向心力指數:按產品
    • 消耗品/試劑
    • 分析儀/配件
    • 軟件服務

第8章全球多重檢測市場:按類型

  • 簡介
  • 市場規模分析和同比增長率(YoY):按類型
  • 市場向心力指數:按類型
    • 蛋白質多重測定
    • 核酸多重測定
    • 基於細胞的多重測定

第9章全球多重檢測市場:按技術

  • 簡介
  • 市場規模分析和同比增長率(按年):按技術
  • 市場向心力指數:按技術
    • 流式細胞儀
    • 螢光檢測
    • 發光檢測
    • 多重實時PCR
    • 其他

第10章全球多重分析市場:按應用

  • 簡介
  • 市場規模分析和同比增長率(YoY):按應用
  • 市場向心力指數:按用途
    • 研發
    • 臨床診斷

第11章全球多重分析市場:按最終用戶分類

  • 簡介
  • 市場規模分析和按年增長率(YoY):按最終用戶劃分
  • 市場向心力指數:按最終用戶劃分
    • 製藥和生物技術公司
    • 醫院/診所
    • 研究所

第12章全球多重分析市場:按地區

  • 簡介
  • 市場規模分析和同比增長率(YoY):按地區
  • 市場向心力指數:按地區
  • 北美
    • 簡介
    • 區域市場的獨特趨勢
    • 市場規模分析和同比增長率(YoY):按產品
    • 市場規模分析和同比增長率(YoY):按類型
    • 市場規模分析和同比增長率(按年):按技術
    • 市場規模分析和同比增長率(YoY):按應用
    • 市場規模分析和同比增長率(YoY):按最終用戶劃分
    • 市場規模分析和同比增長率(yoy):按國家
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第13章全球多重分析市場:競爭形勢

  • 比賽場景
  • 市場定位/份額分析
  • 併購分析(併購)

第14章全球多重分析市場:公司概況

  • Abcam公司
    • 公司簡介
    • 產品組合/概述
    • 最新趨勢
    • 財務分析:概述
  • Becton, Dickinson and Company
  • Bio-Techne
  • Bio-Rad Laboratories
  • Biomerieux SA
  • Hologic Corporation
  • Luminex Corporation
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • HD Biosciences Co., Ltd.

第15章全球多重分析市場:重要討論

第16章關於DataM Intelligence

目錄

Market Overview

A multiplex assay is a kind of immunoassay that utilizes magnetic beads to concurrently measure various analytes in a single experiment. It is a derivative of an ELISA using beads for combining the capture antibody. It offers different advantages over singleplex assays. The requirement for lower sample input has been mentioned to already; typically 25-50 µL sample volume is required to test several markers compared with 100 µL per target required for ELISA.

The global multiplex assays market size was worth US$ XX billion in 2019 and further predicted to reach US$ XX billion by 2027, at a CAGR of XX% during the forecast period (2020-2027).

Market Dynamics

The major factors driving the growth of the multiplex assays market include the adoption of companion diagnostics for improving the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays.

Rising demand for commercial multiplex assays globally

The multiplex assay market is witnessing substantial growth, backed by the increase in R&D activities across the pharmaceutical sector for the treatment of numerous diseases, including chronic diseases. The multiplex assays are used in clinical trials as it has a capability of decreasing the cost of R&D labor and simultaneouly increase the efficiency of therapies and experiments. Moreover, the multiplex assays offer easier and faster analysis of diseases through incorporating automation, thus fueling the multiplex assay market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic is expected to drive the growth of the multiplex assays market during the forecast period. The market has seen a modest increase in 2020, backed by the rise in its adoption during the development of vaccine for the COVID-19. Therefore, a modest growth has been witnessed by the multiplex assays market in 2020.

Segment Analysis

Based on the end-user, the multiplex assays market has been classified into pharmaceutical and biotechnology companies, hospitals & clinics, and research institutes.

Pharmaceutical & biotechnology companies lead the market throughout the forecast period

Pharmaceutical & biotechnology companies segment led the overall market with a share in 2019. This dominance is backed by its growing utilization in discover, manufacturing, and drug development process. Moreover, the increasing adoption of multiplex assays in cancer diagnosis, including bone marrow diseases, immune system diseases, and other infectious diseases are also driving the market.

Based on the product, the multiplex assays market has been classified into consumables and reagents, instruments and accessories, and software and services.

Consumables and reagents segment dominated the global multiplex assays market in 2019

Consumables and reagents segment accounted for the largest share in the global market in 2019. This is owing to the requirement of frequent purchase of kits and reagents, and the increasing number of immunoassay tests performed globally, backed by the rising incidence of chronic and infectious diseases globally. Thermo Fisher Scientific, Siemens Healthineers, and F. Hoffmann-La Roche are some of the major players operating in this market and offering consumables and reagents to the end-users across the globe.

Geographical Analysis

Based on geography, the study analyzes the multiplex assays market in the global market, including North America, South America, Europe, Asia-Pacific, and the Middle East & Africa.

North America leads the global market throughout the forecast period

North America dominates the global multiplex assays market with the largest share in terms of value and volume globally, followed by Europe and Asia Pacific. The US dominated the North American multiplex assay market in 2019. The market is mainly driven by the presence of well-developed technologically advanced healthcare infrastructure in the US coupled with the increasing per capita healthcare expenditure. Moreover, the increase in funding by government agencies and rise in focus to develop innovative drug and biomarkers in this region. Moreover, Asia Pacific is projected to grow at a fastest CAGR in the multiplex assays market during the forecast period. China is estimated to dominate the Asia Pacific market due to the rapidly developing healthcare infrastructure, increase in patient population, and significant rise in R&D activities in pharmaceutical companies in the country.

Competitive Landscape

The multiplex assays market is highly competitive, owing to the large presence of multiplex assays brands. The key multiplex assays players include Abcam Plc, Becton, Dickinson and Company, Bio-Techne, Bio-Rad Laboratories, Biomerieux SA, Hologic Corporation, Luminex Corporation, Seegene Inc., Thermo Fisher Scientific Inc., Merck KGaA, HD Biosciences Co., Ltd. The crucial players are adopting new product launches and expansion strategies for global growth in the multiplex assays market.

Thermo Fisher Scientific Inc.

Overview: Thermo Fisher Scientific Inc. is a medical equipment and devices company based in Massachusetts, the US, and was founded in 1960. The company manufactures scientific instruments, chemicals, and consumables. It offers laboratory equipment, analytical instrument, software, services, reagents, consumables, and supplies to biotech and pharmaceutical, clinical diagnostic labs and hospitals, research institutions, universities, and government agencies. Thermo Fisher operates through Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products & Services segment.

Product Portfolio: The company's portfolio comprises Luminex xMAP (Multi-Analyte Profiling) technology.

Why Purchase the Report?

  • Visualize the multiplex assays market segmentation composition by product, type, technology, application, end-users, and region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the multiplex assays market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of multiplex assays market - level 3 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global multiplex assays market report would provide access to an approx. 68 market data tables, 71 figures, and 273 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Multiplex Assays Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Multiplex Assays Market - Market Definition and Overview

3. Global Multiplex Assays Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Type
  • 3.3. Market Snippet by Technology
  • 3.4. Market Snippet by Application
  • 3.5. Market Snippet by End-Users
  • 3.6. Market Snippet by Region

4. Global Multiplex Assays Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Use of Multiplex Assays in Companion Diagnostics
      • 4.1.1.2. Advantages Over Singleplex and Traditional Assays
    • 4.1.2. Restraints:
      • 4.1.2.1. High Equipment Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Multiplex Assays Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. Global Multiplex Assays Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Multiplex Assays Market - By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 7.3. Market Attractiveness Index, By Product Segment
    • 7.3.1. Consumables and Reagents*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Instruments and Accessories
    • 7.3.3. Software and Services

8. Global Multiplex Assays Market - By Type

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 8.3. Market Attractiveness Index, By Type Segment
    • 8.3.1. Protein Multiplex Assays*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Nucleic Acid Multiplex Assays
    • 8.3.3. Cell-Based Multiplex Assays

9. Global Multiplex Assays Market - By Technology

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
  • 9.3. Market Attractiveness Index, By Technology Segment
    • 9.3.1. Flow Cytometry*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Fluorescence Detection
    • 9.3.3. Luminescence
    • 9.3.4. Multiplex Real-Time PCR
    • 9.3.5. Others

10. Global Multiplex Assays Market - By Application

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 10.3. Market Attractiveness Index, By Application Segment
    • 10.3.1. Research & Development*
      • 10.3.1.1. Introduction
      • 10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 10.3.2. Clinical Diagnostics

11. Global Multiplex Assays Market - By End-Users

  • 11.1. Introduction
  • 11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
  • 11.3. Market Attractiveness Index, By Technology Segment
    • 11.3.1. Pharmaceutical & Biotechnology Companies*
      • 11.3.1.1. Introduction
      • 11.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 11.3.2. Hospitals & Clinics
    • 11.3.3. Research Institutes

12. Global Multiplex Assays Market - By Region

  • 12.1. Introduction
  • 12.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 12.3. Market Attractiveness Index, By Region
  • 12.4. North America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. U.S.
      • 12.4.8.2. Canada
      • 12.4.8.3. Mexico
  • 12.5. Europe
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. Germany
      • 12.5.8.2. U.K.
      • 12.5.8.3. France
      • 12.5.8.4. Italy
      • 12.5.8.5. Spain
      • 12.5.8.6. Rest of Europe
  • 12.6. South America
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
    • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.6.8.1. Brazil
      • 12.6.8.2. Argentina
      • 12.6.8.3. Rest of South America
  • 12.7. Asia Pacific
    • 12.7.1. Introduction
    • 12.7.2. Key Region-Specific Dynamics
    • 12.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
    • 12.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.7.8.1. China
      • 12.7.8.2. India
      • 12.7.8.3. Japan
      • 12.7.8.4. Australia
      • 12.7.8.5. Rest of Asia Pacific
  • 12.8. Middle East and Africa
    • 12.8.1. Introduction
    • 12.8.2. Key Region-Specific Dynamics
    • 12.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 12.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
    • 12.8.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

13. Global Multiplex Assays Market - Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Global Multiplex Assays Market- Company Profiles

  • 14.1. Abcam Plc*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Becton, Dickinson and Company
  • 14.3. Bio-Techne
  • 14.4. Bio-Rad Laboratories
  • 14.5. Biomerieux SA
  • 14.6. Hologic Corporation
  • 14.7. Luminex Corporation
  • 14.8. Seegene Inc.
  • 14.9. Thermo Fisher Scientific Inc.
  • 14.10. Merck KGaA
  • 14.11. HD Biosciences Co., Ltd.

LIST NOT EXHAUSTIVE

15. Global Multiplex Assays Market - Premium Insights

16. Global Multiplex Assays Market - DataM Intelligence

  • 16.1. Appendix
  • 16.2. About Us and Services
  • 16.3. Contact Us